Cardiometabolic & Chronic Care

لماذا يهم

Cardiovascular diseases are the leading cause of death globally — about 19.8 million deaths in 2022, with more than 75% in low- and middle-income countries — and the number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022, fastest in LMICs (WHO, 2025; WHO, 2024). The control gap is stark: of the roughly 1.4 billion adults aged 30–79 with hypertension, two-thirds live in LMICs, about 46% are unaware they have it, and only around 21% have it controlled (WHO, 2025). Standardized programmes close that gap cost-effectively — through the Global Hearts Initiative, more than 13.5 million people across 40-plus LMICs have been put on protocol-based hypertension treatment (WHO, 2025).

InBasket AI keeps chronic cardiometabolic care on one continuous record so a small care team can work from a single, trustworthy source of truth — part of expanding access to care for the next billion people.

مصمم بالاستناد إلى معايير عالمية ووطنية وسريرية معترف بها

صمم مجال الرعاية هذا بالاستناد إلى منظومة أوسع من المعايير، تشمل الإرشادات العالمية والبروتوكولات الوطنية وتوصيات الجمعيات المتخصصة ومعايير التشغيل البيني ومتطلبات تقارير البرامج عند الاقتضاء:

• WHO HEARTS technical package and Package of Essential NCD (PEN) interventions
• KDIGO CKD staging and renal-risk medication-safety guidance
• International Diabetes Federation / ADA Standards of Care diabetes-management principles where locally adopted
• ACC/AHA, ESC, or national cardiovascular-risk and hypertension guidance where locally adopted
• National Ministry of Health standard treatment guidelines, essential medicines lists, and local scope-of-practice rules for the implementation setting
• HL7 FHIR, ICD-10, LOINC, SNOMED CT, and local terminology/coding standards where adopted
• بروتوكولات وزارة الصحة، وإرشادات العلاج الوطنية، وقوائم الأدوية الأساسية، وقواعد نطاق الممارسة في بيئة التنفيذ
• معايير HL7 FHIR وICD-10 وLOINC وSNOMED CT والمصطلحات/الترميزات المحلية عند اعتمادها

مصادر المعايير

تدعم هذه المصادر المعايير المذكورة أعلاه. وتختار البروتوكولات الوطنية الخاصة بكل تنفيذ من الجهات الوطنية أو الإقليمية الرسمية أثناء النشر.

1. [1]World Health Organization guidelines and publications
2. [2]KDIGO guidelines
3. [3]Official national Ministry of Health protocols for the implementation setting — Implementation-specific: selected from the official national or regional authority during deployment.
4. [4]American Diabetes Association Standards of Care
5. [5]ACC/AHA clinical guidance
6. [6]European Society of Cardiology guidelines
7. [7]HL7 FHIR
8. [8]WHO ICD classifications
9. [9]LOINC
10. [10]SNOMED CT

مصادر الأدلة

• WHO Cardiovascular diseases (2025)
• ·WHO Diabetes (2024)
• ·WHO Hypertension (2025)